Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianer Qingjie Granules
- Development stage
- Unknown
- Lead developer
- China National Pharmaceutical Industry Research Institute
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Jianer Qingjie Granules is a Traditional Chinese Medicine (TCM) botanical formulation developed for pediatric use. It is primarily indicated for the treatment of acute upper respiratory tract infections (AURTI) in children and adolescents, specifically targeting the TCM pattern of wind-heat with internal stagnation (风热夹滞证). The formulation typically consists of several herbal extracts, including Lonicera japonica (honeysuckle), Forsythia suspensa, and Hawthorn, which are traditionally used to clear heat, detoxify the body, and resolve food stagnation. The drug is currently being evaluated in Phase II clinical trials in China to assess its safety, tolerability, and preliminary efficacy in managing respiratory symptoms and associated digestive disharmony in the pediatric population.
- Brand names
- Jianer Qingjie Granules
- Other names
- Jianer Qingjie Keli健儿清解颗粒
Beyond the preview
Go deeper on Jianer Qingjie Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jianer Qingjie Granules.